VectorLogics' Core Technologies and Applications VectorLogics has an intellectual property portfolio that includes 36 issued or allowed US and foreign patents serving as the foundation for the development of its molecular medicines. Molecularly targeted vectors can solve the problem of delivering and maintaining therapeutic levels of protein at the site of disease. Similarly to medicinal chemistry that modifies small chemical moieties for drug development, VLI uses “Medicinal Biology” to modify the adenovectors for increased efficiency and safety. These technologies can be applied to different treatment modalities or can be combined in a single vector for maximum efficacy.